Cargando…

Amyloid Beta in Aging and Alzheimer’s Disease

Alzheimer’s disease (AD), is a progressive neurodegenerative disease that affects behavior, thinking, learning, and memory in elderly individuals. AD occurs in two forms, early onset familial and late-onset sporadic; genetic mutations in PS1, PS2, and APP genes cause early onset familial AD, and a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sehar, Ujala, Rawat, Priyanka, Reddy, Arubala P., Kopel, Jonathan, Reddy, P. Hemachandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655207/ https://www.ncbi.nlm.nih.gov/pubmed/36361714 http://dx.doi.org/10.3390/ijms232112924

Ejemplares similares

Therapeutics of Alzheimer’s Disease: Recent Developments
por: Burns, Scott, et al.
Publicado: (2022)

Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in African Americans: Focus on Caregivers
por: Kopel, Jonathan, et al.
Publicado: (2023)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Support Provided by Caregivers for Community-Dwelling Diabetic Hispanic Adults with Intellectual Disabilities and Comorbid Conditions
por: Rawat, Priyanka, et al.
Publicado: (2023)

Caregivers with Cancer Patients: Focus on Hispanics
por: Bisht, Jasbir, et al.
Publicado: (2023)

Support Provided by Caregivers for Community-Dwelling Obesity Individuals: Focus on Elderly and Hispanics
por: Basu, Tanisha, et al.
Publicado: (2023)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
por: Reddy, P. Hemachandra, et al.
Publicado: (2019)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022)

Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer’s Disease
por: Bhatti, Gurjit Kaur, et al.
Publicado: (2020)

Comprehensive Understanding of Hispanic Caregivers: Focus on Innovative Methods and Validations
por: Sehar, Ujala, et al.
Publicado: (2023)

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
por: Calkins, Marcus J., et al.
Publicado: (2012)

A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022)

Current Status of Obesity: Protective Role of Catechins
por: Basu, Tanisha, et al.
Publicado: (2023)

Mitochondrial Oxidative Damage in Aging and Alzheimer's Disease: Implications for Mitochondrially Targeted Antioxidant Therapeutics
por: Reddy, P. Hemachandra
Publicado: (2006)

Age-Related Chronic Diseases and Alzheimer’s Disease in Texas: A Hispanic Focused Study
por: Sheladia, Shyam, et al.
Publicado: (2021)

The Role of Obesity and Diabetes in Dementia
por: Selman, Ashley, et al.
Publicado: (2022)

Defective Autophagy and Mitophagy in Aging and Alzheimer’s Disease
por: Tran, Michael, et al.
Publicado: (2021)

Dynamics of Dynamin-Related Protein 1 in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Oliver, Darryll, et al.
Publicado: (2019)

Emerging role of non‐coding RNA in health and disease
por: Bhatti, Gurjit Kaur, et al.
Publicado: (2021)

Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection
por: Bhatti, Jasvinder Singh, et al.
Publicado: (2020)

Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases
por: John, Albin, et al.
Publicado: (2020)

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges
por: Dewanjee, Saikat, et al.
Publicado: (2021)

Can healthy lifestyle reduce disease progression of Alzheimer’s during a global pandemic of COVID-19?
por: John, Albin, et al.
Publicado: (2021)

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
por: Cheignon, C., et al.
Publicado: (2017)

MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An Update
por: Kumar, Subodh, et al.
Publicado: (2018)

Protective Effects of Chaya against Mitochondrial and Synaptic Toxicities in the Type 2 Diabetes Mouse Model TallyHO
por: Ramasubramanian, Bhagavathi, et al.
Publicado: (2022)

Amyloid-beta immunotherapy: the hope for Alzheimer disease?
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)

Toxicity of Neurons Treated with Herbicides and Neuroprotection by Mitochondria-Targeted Antioxidant SS31
por: Reddy, Tejaswini P., et al.
Publicado: (2011)

Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases
por: Ganji, Riya, et al.
Publicado: (2021)

Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease
por: Reddy, P Hemachandra, et al.
Publicado: (2016)

Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2019)

Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases
por: Bhatti, Gurjit Kaur, et al.
Publicado: (2022)

Structural and physiological changes of the kidney with age and its impact on chronic conditions and COVID-19
por: Ray, Nandini, et al.
Publicado: (2023)

The amyloid beta ion channel hypothesis of Alzheimer’s disease
por: Shirwany, Najeeb A, et al.
Publicado: (2007)

Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
por: Sadigh-Eteghad, Saeed, et al.
Publicado: (2015)

Natural Products Targeting Amyloid Beta in Alzheimer’s Disease
por: Lee, Joo-Hee, et al.
Publicado: (2021)

Optical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
por: Luo, Ziyi, et al.
Publicado: (2021)

Reduced VDAC1, Maintained Mitochondrial Dynamics and Enhanced Mitochondrial Biogenesis in a Transgenic Tau Mouse Model of Alzheimer’s Disease
por: Vijayan, Murali, et al.
Publicado: (2022)

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
por: Moro, Maria Luisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8jih73ir1rfef7s7l9hgqh4fk0